Investigators from the Veteran’s Affairs Center for Innovation to Implementation and Stanford University searched publication databases through June 2022 for observational studies about methamphetamine-associated heart failure.
Your search for major depressive disorder returned 29 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Investigators looked into which treatment fared better for patients with anxiety disorders: a mindfulness-based stress reduction intervention or escitalopram.
Researchers assessed characteristics and correlates of metabolic syndrome in adolescents with major depressive disorder or bipolar disorder depression.
Researchers searched for protective effects in gut microbiota from the pathogenesis of major depressive disorder.
Researchers evaluated the efficacy of dextromorphan-bupropion among patients with major depressive disorder and comorbid anxiety.
Researchers compared the white matter networks of patients with remitted major depressive disorder and remitted bipolar disorder to find disease-specific alterations.
The researchers sought to examine whether inflammation and white matter microstructure play a role in treatment response in major depressive disorder.
Outpatients were recruited at the Instituto Nacional de Psiquiatía (National Institute of Psychiatry) in Mexico and were evaluated for alcohol dependence and major depressive disorder.
For this study, community-dwelling adults were evaluated for major depressive disorder, generalized anxiety disorder, and global sleep quality over an 18 year period.
Patients with somatoform disorders, major depressive disorder, and healthy controls were recruited between 2016 and 2017 at the Ambulante Psychosoziale Rehabilitation in Austria and Schoen Clinic Roseneck in Germany.
Patients with treatment-resistant major depressive disorder or bipolar disorder without psychotic symptoms received intravenous infusions of 0.5 mg/kg ketamine 3 times per week for 2 weeks.
Psilocybin has been shown to have antidepressant properties. With direct comparisons between psilocybin and established treatments for depression lacking, the study researchers looked at psilocybin and escitalopram.
Major depressive episodes reduce visual contrast suppression among patients with depressive disorders, a study shows.
Data for this study were sourced from 4 active treatment arms of 4 randomized, controlled trials conducted by the National Institutes of Health in the United States between 2006 and 2018.
Researchers from Dalhousie University in Canada searched publication databases through September of 2020 for articles on ADHD, attention deficit disorder, bipolar disorder, and affective psychosis.
A cross-sectional family study sought to determine if parents’ transmission of anxiety is sex specific.
Researchers examined associations between polygenic risk scores and neuropsychiatric conditions using data from phenome-wide association studies.
For this study, patients with generalized anxiety disorder were recruited from the Nanfang Hospital in China between 2018 and 2020.
This observational study was conducted by telephone interviews between April and July 2020.
Inpatients with persistent depressive disorder were recruited at a German University Hospital for a 10-week inpatient treatment with the Cognitive Behavioral Analysis System of Psychotherapy.
Researchers investigated whether individuals with symptoms of depression were more sensitive to missed opportunities.
Investigators sourced data from the Norwegian Mother, Father and Child Cohort Study which was a population-based pregnancy cohort study conducted between 1999 and 2008.
Researchers investigated whether lurasidone monotherapy would improve health-related quality of life.
Reddit posts from forums discussing self-harm were used to characterize and quantify the addiction language and to evaluate the extent to which individuals who engage in self-harm feel they are suffering from an addiction.
Researchers investigated whether earlier initiation of paliperidone palmitate was associated with fewer events of treatment failure due to hospitalization, arrest, or incarceration compared with oral antipsychotics among patients with schizophrenia.
The Cantabria Early Intervention in Psychosis Program (PAFIP) was conducted between 2012 and 2018 in Spain.
Researchers investigated whether there were identifiable treatment-specific and shared predictors for response to pharmacotherapies for ADHD among children.
In a randomized clinical trial, researchers observed the efficacy of escitalopram compared with exercise training and placebo in reducing anxiety in patients with CHD.
Pregnant women with a psychiatric disorder or receiving psychiatric medications were recruited to test the efficacy of online cognitive behavioral therapy to manage stress during the COVID-19 pandemic.